[1] Richardson SM, Kalamegam G, Pushparaj PN, et al.Mesenchymal stem cells in regenerative medicine: focus on articular cartilage and intervertebral disc regeneration[J]. Methods, 2016, 99: 69-80.
[2] Pu L, Meng M, Wu J, et al.Compared to the amniotic membrane, Wharton's jelly may be a more suitable source of mesenchymal stem cells for cardiovascular tissue engineering and clinical regeneration[J]. Stem Cell Res Ther, 2017, 8(1): 72.
[3] Zuk PA, Zhu M, Mizuno H, et al.Multilineage cells from human adipose tissue: implications for cell-based therapies[J]. Tissue Eng, 2001, 7(2): 211-228.
[4] Zannettino AC, Paton S, Itescu S, et al.Comparative assessment of the osteoconductive properties of different biomaterials in vivo seeded with human or ovine mesenchymal stem/stromal cells[J]. Tissue Eng Part A, 2010, 16(12): 3579-3587.
[5] Yu X, Li Q, Ren MF, et al. Expression difference of surface markers between adipose derivedmesenchymal stem cells and bone marrow mesenchymalstem cells of the mouse[J]. Acta Anatomica Sinica,2016,47(2): 203-208. (in Chinese)
余霞, 李琼, 任明芬, 等.小鼠脂肪源和骨髓源间充质干细胞表面标记表达的比较[J]. 解剖学报, 2016, 47(2): 203-208.
[6] Gaebel R, Furlani D, Sorg H, et al.Cell origin of human mesenchymal stem cells determines a different healing performance in cardiac regeneration[J]. PLoS One, 2011, 6(2): e15652.
[7] De Witte SFM, Peters FS, Merino A, et al.Epigenetic changes in umbilical cord mesenchymal stromal cells upon stimulation and culture expansion[J]. Cytotherapy, 2018, 20(7): 919-929.
[8] Yang YK, Ogando CR, Wang See C, et al.Changes in phenotype and differentiation potential of human mesenchymal stem cells aging in vitro[J]. Stem Cell Res Ther, 2018, 9(1): 131.
[9] Garcia-Olmo D, GarciaArranz M, Herreros D, et al.A phase Ⅰ clinical trial of the treatment of Crohn’s-fistula by adipose mesenchymal stem cell transplantation[J]. Dis Colon Rectum, 2005, 48(7): 1416-1423.
[10]Wan Safwani WK, Makpol S, Sathapan S, et al.The changes of stemness biomarkers expression in human adipose-derived stem cells during long-term manipulation[J]. Biotechnol Appl Biochem, 2011, 58(4): 261-270.
[11]Choi MR, Kim HY, Park JY, et al.Selection of optimal passage of bone marrow-derived mesenchymal stem cells for stem cell therapy in patients with amyotrophic lateral sclerosis[J]. Neurosci Lett, 2010, 472(2): 94-98.
[12]Kim J, Kang JW, Park JH, et al.Biological characterization of long-term cultured human mesenchymal stem cells[J]. Arch Pharm Res, 2009, 32(1): 117-126.
[13]Javazon EH, Beggs KJ, Flake AW.Mesenchymal stem cells: paradoxes of passaging[J]. Exp Hematol, 2004, 32(5): 414-425.
[14]Park JS, Kim HY, Kim HW, et al.Increased caveolin-1, a cause for the declined adipogenic potential of senescent human mesenchymal stem cells[J]. Mech Ageing Dev, 2005, 126(5): 551-559.
[15]Calloni R, Cordero EA, Henriques JA, et al.Reviewing and updating the major molecular markers for stem cells[J]. Stem Cells Dev, 2013, 22(9): 1455-1476.
[16]Christ B, Pelz S.Implication of hepatic stem cells in functional liver repopulation[J]. Cytometry A, 2013, 83(1): 90-102.
[17]Haasters F, Prall WC, Anz D, et al.Morphological and immunocytochemical characteristics indicate the yield of early progenitors and represent a quality control for human mesenchymal stem cell culturing[J]. J Anat, 2009, 214(5): 759-767.
[18]Hao H, Chen G, Liu J, et al.Culturing on Wharton’s jelly extract delays mesenchymal stem cell senescence through p53 and p16INK4a/pRb pathways[J]. PLoS One, 2013, 8(3): e58314.
[19]Joseph M, Das M, Kanji S, et al.Retention of stemness and vasculogenic potential of human umbilical cord blood stem cells after repeated expansions on PES-nanofiber matrices[J]. Biomaterials, 2014, 35(30): 8566-8575.
[20]Zhang D, Kilian KA.The effect of mesenchymal stem cell shape on the maintenance of multipotency[J]. Biomaterials, 2013, 34(16): 3962-3969.
[21]Elahi KC, Klein G, Avci-Adali M, et al.Human mesenchymal stromal cells from different sources diverge in their expression of cell surface proteins and display distinct differentiation patterns[J]. Stem Cells Int, 2016, 2016: 5646384.
[22]Leblanc R, Lee SC, David M, et al.Interaction of platelet-derived autotaxin with tumor integrin alphaVbeta3 controls metastasis of breast cancer cells to bone[J]. Blood, 2014, 124(20): 3141-3150.
[23]Peng ST, Su CH, Kuo CC, et al.CD44 crosslinking-mediated matrix metalloproteinase-9 relocation in breast tumor cells leads to enhanced metastasis[J]. Int J Oncol, 2007, 31(5): 1119-1126.
[24]Wang Y, Li Q, Zhang SL, et al. Effect of CD73 on the proliferation and senescence of bone marrow mesenchymal stem cells[J]. Acta Anatomic Sinica,2017,48(6): 669-674. (in Chinese)
王琰, 李琼, 张三林, et al.CD73对骨髓间充质干细胞增殖与衰老的影响[J]. 解剖学报, 2017, 48(6): 669-674.
[25]Yao Y, Pan Y, Chen J, et al.Endoglin (CD105) expression in angiogenesis of primary hepatocellular carcinomas: analysis using tissue microarrays and comparisons with CD34 and VEGF[J]. Ann Clin Lab Sci, 2007, 37(1): 39-48.
[26]Ishimura D, Yamamoto N, Tajima K, et al.Differentiation of adipose-derived stromal vascular fraction culture cells into chondrocytes using the method of cell sorting with a mesenchymal stem cell marker[J]. Tohoku J Exp Med, 2008, 216(2): 149-156.
[27]Chang Y, Li C, Jia Y, et al.CD90+ cardiac fibroblasts reduce fibrosis of acute myocardial injury in rats[J]. Int J Biochem Cell Biol, 2018, 96: 20-28.
|